From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary
The Role of Race in Vaccine Acceptance in Routine and Crisis Contexts
Sandra Quinn, PhD
142nd APHA Annual Meeting and Exposition 2014
Session Objectives: To effectively tailor communications to promote vaccine uptake, researchers must examine the social, cultural, familial and structural factors that may influence vaccine uptake. In this session, we will explore and compare vaccine disparities and communication inequalities in the context of Public Health Critical Race Praxis.
Understanding HPV Vaccine Uptake Among Cambodian American Girls
142nd APHA Annual Meeting and Exposition 2014
Linda Ko, PhD , Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA; Vicky Taylor, MD, MPH , Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Nancy Burke, PhD , Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA; Channdara Sos, MBA , Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA
Qi Liu, MS , Department of Public Health Sciences, University of Alberta, Edmonton, AB, Canada
Hoai Do, MPH , Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA; Jocelyn Talbot, BA , Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; Yutaka Yasui, PhD , School of Public Health, University of Alberta, Edmonton, AB, Canada ;Roshan Bastani, PhD , UCLA School of Public Health, Department of Health Policy and Management, Jonsson Comprehensive Cancer Center, Cancer Prevention and Control Research, Los Angeles, CA
Introduction: Cervical cancer incidence rates vary substantially among racial/ethnic groups in the US with women of Southeast Asian descent having the highest rates. Up to 70% of cervical cancers could be prevented by widespread use of the HPV vaccine. There is a lack of information about HPV vaccine uptake among Southeast Asian girls. Our objective was to examine HPV vaccination barriers, facilitators, and uptake in a Cambodian immigrant community.
Methods: We conducted a telephone survey of Cambodian women with daughters who were age-eligible for HPV vaccination in 2013. Our study group included 86 Cambodian mothers who lived in the Seattle metropolitan area.
Results: Nearly all (96%) of our survey participants were foreign-born and over one-half (51%) had limited English proficiency. The proportions of mothers who reported their daughter had initiated and completed the HPV vaccine series were only 29% and 14%, respectively. Higher levels of vaccine uptake were significantly associated with mothers having heard about the HPV vaccine from a health professional and having received a recent Pap test. Commonly cited barriers to HPV vaccination included lack of knowledge about the HPV vaccine, not having received a physician recommendation for HPV vaccination, and thinking the HPV vaccine is unnecessary in the absence of health problems.
Conclusion: Linguistically and culturally appropriate HPV educational programs should be developed and implemented in Cambodian immigrant communities. These programs should aim to enhance understanding of disease prevention measures, increase knowledge about the HPV vaccine, and empower women to ask their daughters’ doctors for HPV vaccination.
BMC Infectious Diseases
Accessed 14 June 2014
A systematic review of the epidemiology of hepatitis E virus in Africa
Jong-Hoon Kim1, Kenrad E Nelson2, Ursula Panzner1, Yogita Kasture1, Alain B Labrique2 and Thomas F Wierzba1*
Hepatitis E Virus (HEV) infection is a newly recognized serious threat to global public health and Africa is suspected to be among the most severely affected regions in the world. Understanding HEV epidemiology in Africa will expedite the implementation of evidence-based control policies aimed at preventing the spread of HEV including policies for the use of available resources such as HEV vaccines.
Here we present a comprehensive review of HEV epidemiology in Africa based on published data. We searched for articles on HEV epidemiology in Africa from online databases such as PubMed, Scopus, and ISI Web of Science and critically reviewed appropriate publications to extract consistent findings, identify knowledge gaps, and suggest future studies.
Taking a particularly high toll in pregnant women and their fetuses, HEV has infected human populations in 28 of 56 African countries. Since 1979, 17 HEV outbreaks have been reported about once every other year from Africa causing a reported 35,300 cases with 650 deaths.
In Africa, HEV infection is not new, is widespread, and the number of reported outbreaks are likely a significant underestimate. The authors suggest that this is a continent-wide public health problem that deserves the attention of local, regional and international agencies to implement control policies that can save numerous lives, especially those of pregnant women and their fetuses.